Mitsubishi UFJ Asset Management’s Parabilis Medicines Inc PBLS Stock Holding History

Mitsubishi UFJ Asset Management’s Portfolio PBLS Stock Details PBLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$526K	Buy	+19,200	New	+$530K	﹤0.01%	914

Other funds holding PBLS

Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return

Regeneron Pharmaceuticals Tarrytown, New York $177M AUM 9.82% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return

Winton Group London, United Kingdom $3.09B AUM 40.4% 1-Year Est. Return

PAP

Persistent Asset Partners Hong Kong $335M AUM 275.57% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

CUAMC

China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return

Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return

BIA

Bell Investment Advisors Oakland, California $681M AUM 18.36% 1-Year Est. Return

Mitsubishi UFJ Asset Management's PBLS Position: Q2 2026 in Review

Mitsubishi UFJ Asset Management opened a new position in Parabilis Medicines Inc (PBLS) in Q2 2026: 19,200 shares worth $526K. The stake represents ﹤0.01% of the portfolio and ranks #914 among its holdings.

17 funds tracked by Wall St. Rank hold PBLS as of Q2 2026.

Mitsubishi UFJ Asset Management held 19,200 shares of Parabilis Medicines Inc worth $526K as of Q2 2026.
Parabilis Medicines Inc was a new Mitsubishi UFJ Asset Management position in Q2 2026.
Parabilis Medicines Inc made up ﹤0.01% of Mitsubishi UFJ Asset Management's portfolio in Q2 2026, its #914 holding.
17 funds tracked by Wall St. Rank held Parabilis Medicines Inc as of Q2 2026.

Based on Mitsubishi UFJ Asset Management's 13F filing for Q2 2026, filed 7 Aug 2026.